Dr. Nandu Thalange is Consultant Paediatric Endocrinologist at Al Jalila Children’s and graduated from King’s College, London in 1988, intent on a career in paediatric endocrinology. After junior posts at King’s College Hospital and other hospitals around London, he moved to the Royal Manchester Children’s Hospital to take up a research training post in paediatric endocrinology. His research at that time was focused primarily on the physiology of normal and abnormal growth and culminated in 3 significant papers in the Journal of Clinical Endocrinology and Metabolism, Pediatric Research and Archives of Diseases of Childhood.
After completing his research post, Dr. Nandu moved to East Anglia, completing his training in Norwich and Cambridge, including a year in child public health. In 2002, Nandu took up a post as a Consultant Paediatric Endocrinologist at the Norfolk and Norwich University Hospital in East Anglia, until he left in April 2017. He ran a large paediatric endocrinology, diabetes and weight management service, including specialist clinics for neurofibromatosis, achondroplasia and bone disease, notably osteoporosis and osteogenesis imperfecta. The diabetes service had over 350 children and adolescents with diabetes (including 60% on insulin pumps), and achieved excellent results in the National Diabetes Audit.
Dr. Nandu has been an investigator in a number of collaborative multicentre research studies, in diabetes and endocrinology, including being chief investigator for the international multi-centre trials that led to the approval of insulin detemir and insulin degludec in children, worldwide. His other research interests include hypertension, (he co-authored a paper on the normal ranges for blood pressure in Great Britain, based on an analysis of over 20000 children and young adults), psychological impacts of disease, epidemiology, and child public health, particularly avoidable child mortality. He is a public speaker and frequently presents to international audiences.